Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
By type, the Global Levonorgestrel API market share is the highest in the short-acting contraceptive API, about 67.17%. The most proportion of the Global Levonorgestrel API market share is used for Levonorgestrel Tablet and the proportion is about 52.74% in 2020.

Market Analysis and Insights: Global Levonorgestrel API Market
The global Levonorgestrel API market is valued at US$ 47 million in 2019. The market size will reach US$ 58 million by the end of 2026, growing at a CAGR of 4.0% during 2021-2026.

Global Levonorgestrel API Scope and Market Size
Levonorgestrel API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Levonorgestrel API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Short-Acting Contraceptive API
Long-Acting Contraceptive API

Segment by Application
Levonorgestrel Tablet
Mixture Products
Hormone-releasing IUD

By Company
Bayer HealthCare
Qinhuangdao Zizhu Pharmaceutical
Yangzhou Pharmaceutical
Lupin
Hubei Gedian Humanwell
Sterling Spa
Formos
Huazhong Pharm
ASG Biochem

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia